Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Pedraz Penalva

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Reumatologia Clinica|July 6, 2025
One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registryClementina López-Medina, Lucía Otero-Varela, Fernando Sánchez-Alonso, et al.
Frontiers in Medicine|December 6, 2023
Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritisJuan José Alegre-Sancho, Victoria Núñez-Monje, Cristina Campos-Fernández, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Reumatologia Clinica|July 6, 2025
One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registryClementina López-Medina, Lucía Otero-Varela, Fernando Sánchez-Alonso, et al.
Frontiers in Medicine|December 6, 2023
Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritisJuan José Alegre-Sancho, Victoria Núñez-Monje, Cristina Campos-Fernández, et al.
Pageof 1